{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:04:58Z","timestamp":1787321098237,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016971","name":"Lomonosov Moscow State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["22-15-00098-P"],"award-info":[{"award-number":["22-15-00098-P"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118433","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T07:53:42Z","timestamp":1764834822000},"page":"118433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A series of conjugates based on prostate-specific membrane antigen ligands with the chelating agent DOTA: synthesis, radiolabeling, and biological activity"],"prefix":"10.1016","volume":"303","author":[{"given":"N.S.","family":"Butakova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Uspenskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.Y.","family":"Zyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Petrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Popovicheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Lunev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Petrosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.A.","family":"Mitrofanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.N.","family":"Ivashkovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Evteev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.A.","family":"Ivanenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.K.","family":"Beloglazkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Larenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7975-0346","authenticated-orcid":false,"given":"A.E.","family":"Machulkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118433_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.118433_bib2","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1200\/JCO.19.00799","article-title":"Arches: a randomized, phase III study of androgen deprivation therapy with enzalutamide or placebo in men with metastatic hormone-sensitive prostate cancer","volume":"37","author":"Armstrong","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2025.118433_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11701-015-0550-z","article-title":"Robotic-assisted laparoscopic prostatectomy (RALP): a new way to training","volume":"10","author":"Rocha","year":"2016","journal-title":"J. Robot. Surg."},{"key":"10.1016\/j.ejmech.2025.118433_bib4","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.7150\/thno.31806","article-title":"The search for an alternative to [68Ga]Ga-DOTA-TATE in neuroendocrine tumor theranostics: current state of 18F-labeled somatostatin analog development","volume":"9","author":"Waldmann","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2025.118433_bib5","first-page":"467","article-title":"Re: Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer","volume":"207","author":"Sartor","year":"2022","journal-title":"J. Urol."},{"key":"10.1016\/j.ejmech.2025.118433_bib6","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1471-4159.1988.tb10593.x","article-title":"Hydrolysis of the brain dipeptide N\u2010Acetyl\u2010l\u2010Aspartyl\u2010l\u2010Glutamate: subcellular and regional distribution, ontogeny, and the effect of lesions on N\u2010Acetylated\u2010\u03b1\u2010Linked acidic dipeptidase activity","volume":"50","author":"Blakely","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2025.118433_bib7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2967\/jnumed.117.203877","article-title":"A perspective on the evolving story of PSMA biology, PSMA-based imaging, and endoradiotherapeutic strategies","volume":"59","author":"O'Keefe","year":"2018","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2025.118433_bib8","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1039\/D1CC05810J","article-title":"Prostate-specific membrane antigen (PSMA) targeted singlet oxygen delivery via endoperoxide tethered ligands","volume":"58","author":"Wang","year":"2022","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2025.118433_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/ncpuro0452","article-title":"Technology insight: monoclonal antibody imaging of prostate cancer","volume":"3","author":"Bander","year":"2006","journal-title":"Nat. Clin. Pract. Urol."},{"key":"10.1016\/j.ejmech.2025.118433_bib10","first-page":"1747","article-title":"Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy","volume":"6","author":"Wu","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2025.118433_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ph16020315","article-title":"PSMA-targeted nanotheranostics for imaging and radiotherapy of prostate cancer","volume":"16","author":"Meher","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.118433_bib12","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s10517-016-3490-3","article-title":"Nanohybride materials based on magnetite-gold nanoparticles for diagnostics of prostate cancer: synthesis and in vitro testing","volume":"161","author":"Machulkin","year":"2016","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.ejmech.2025.118433_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/magnetochemistry8120185","article-title":"Bifunctional magnetite\u2013gold nanoparticles for magneto-mechanical actuation and cancer cell destruction","volume":"8","author":"Garanina","year":"2022","journal-title":"Magnetochemistry"},{"key":"10.1016\/j.ejmech.2025.118433_bib14","first-page":"1","article-title":"Good practices for 68Ga radiopharmaceutical production, EJNMMI Radiopharm","volume":"7","author":"Nelson","year":"2022","journal-title":"Chem"},{"key":"10.1016\/j.ejmech.2025.118433_bib15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2967\/jnumed.119.234922","article-title":"Radiohybrid ligands: a novel tracer concept exemplified by 18F- or 68Ga-labeled rhPSMA inhibitors","volume":"61","author":"Wurzer","year":"2020","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2025.118433_bib16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1021\/jm000406m","article-title":"Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase)","volume":"44","author":"Kozikowski","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118433_bib17","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1021\/jm800765e","article-title":"Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterization","volume":"51","author":"Barinka","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118433_bib18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1021\/jm950801q","article-title":"Design, synthesis, and biological activity of a potent inhibitor of the neuropeptidase N-acetylated \u03b1-linked acidic dipeptidase","volume":"39","author":"Jackson","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118433_bib19","doi-asserted-by":"crossref","first-page":"12711","DOI":"10.1021\/ja104591m","article-title":"A Remote arene-binding site on prostate specific membrane antigen revealed by antibody-recruiting small molecules","volume":"132","author":"Zhang","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118433_bib20","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/j.bmc.2014.05.061","article-title":"Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery","volume":"22","author":"Tykvart","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118433_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128840","article-title":"Synthesis and initial in vitro evaluation of PSMA-targeting ligands with a modified aromatic moiety at the lysine \u03b5-nitrogen atom","volume":"71","author":"Zyk","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118433_bib22","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/sj.emboj.7600969","article-title":"Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer","volume":"25","author":"Mesters","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2025.118433_bib23","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/bc3003919","article-title":"SYnthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen","volume":"23","author":"Chen","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2025.118433_bib24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1021\/mp9000712","article-title":"Design, synthesis, and preclinical evaluation of prostate-specific membrane antigen targeted 99mTc-radioimaging agents","volume":"6","author":"Kularatne","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2025.118433_bib25","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1021\/mp900069d","article-title":"Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand","volume":"6","author":"Kularatne","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2025.118433_bib26","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1021\/acs.jmedchem.0c01935","article-title":"Synthesis and biological evaluation of PSMA ligands with aromatic residues and fluorescent conjugates based on them","volume":"64","author":"Machulkin","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118433_bib27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.mencom.2020.11.022","article-title":"Influence of the dipeptide linker configuration on the activity of PSMA ligands","volume":"30","author":"Uspenskaya","year":"2020","journal-title":"Mendeleev Commun."},{"key":"10.1016\/j.ejmech.2025.118433_bib28","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2967\/jnumed.115.158550","article-title":"68Ga-and 177Lu-labeled PSMA i and T: optimization of a PSMA-targeted theranostic concept and first proof-of-concept human studies","volume":"56","author":"Weineisen","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2025.118433_bib29","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/acsptsci.4c00070","article-title":"Synthesis and preclinical evaluation of urea-based prostate-specific membrane antigen-targeted conjugates labeled with 177Lu","volume":"7","author":"Machulkin","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejmech.2025.118433_bib30","doi-asserted-by":"crossref","first-page":"10960","DOI":"10.1021\/ic101378s","article-title":"Gallium(III) complexes of DOTA and DOTA-Monoamide: kinetic and thermodynamic studies","volume":"49","author":"Kub\u00ed\u010dek","year":"2010","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118433_bib31","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2967\/jnumed.114.147413","article-title":"Preclinical evaluation of a tailor-made DOTA-conjugated PSMA inhibitor with optimized linker moiety for imaging and endoradiotherapy of prostate cancer","volume":"56","author":"Benesov\u00e1","year":"2015","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2025.118433_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nucmedbio.2017.12.007","article-title":"Synthesis and evaluation of a novel urea-based 68Ga-complex for imaging PSMA binding in tumor","volume":"59","author":"Zha","year":"2018","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2025.118433_bib33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11307-015-0850-8","article-title":"Initial evaluation of [18F]DCFPyL for Prostate-Sprostate-smbrane Amtigen (PaMA)-Targeted PET Imaging ofiProstate Cpncer","volume":"17","author":"Szabo","year":"2015","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.ejmech.2025.118433_bib34","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1021\/acs.jmedchem.5b01210","article-title":"Linker modification strategies to control the prostate-specific membrane antigen (PSMA)-Targeting and pharmacokinetic properties of DOTA-Conjugated PSMA inhibitors","volume":"59","author":"Bene\u0161ov\u00e1","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118433_bib35","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s11307-019-01421-7","article-title":"[68Ga]Ga-P16-093 as a PSMA-Targeted PET Radiopharmrceutical for Detection df Cancer: Inctial Eviluationeand Comparisoncwith [68Ga]Ga-PSMA-11 in Prostate Cancer Patipnts Prescnting pith Biocpemical Recurrenbe","volume":"22","author":"Green","year":"2020","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.ejmech.2025.118433_bib36","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2967\/jnumed.115.171397","article-title":"PSMA-targeted radionuclide therapy of metastatic castration-resistant prostate cancer with 177Lu-Labeled PSMA-617","volume":"57","author":"Kratochwil","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ejmech.2025.118433_bib37","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","article-title":"F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients","volume":"44","author":"Giesel","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.ejmech.2025.118433_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00044-022-03002-w","article-title":"Optimization of the dipeptide motifs in the PSMA ligands linker structure: synthesis and in vitro evaluation","volume":"32","author":"Uspenskaya","year":"2023","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.118433_bib39","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.mencom.2023.06.010","article-title":"Choice of the optimal synthetic approach for the polypeptide ligands of prostatic specific membrane antigen preparation","volume":"33","author":"Zyk","year":"2023","journal-title":"Mendeleev Commun."},{"key":"10.1016\/j.ejmech.2025.118433_bib40","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1021\/acs.jmedchem.0c01935","article-title":"Synthesis and biological evaluation of PSMA ligands with aromatic residues and fluorescent conjugates based on them","volume":"64","author":"Machulkin","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118433_bib41","series-title":"Solid Phase Peptide Synthesis, De Novo Peptide Design: Principles and Applications","first-page":"57","author":"Goyal","year":"2022"},{"key":"10.1016\/j.ejmech.2025.118433_bib42","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.mencom.2023.06.010","article-title":"Choice of the optimal synthetic approach for the polypeptide ligands of prostatic specific membrane antigen preparation","volume":"33","author":"Zyk","year":"2023","journal-title":"Mendeleev Commun."},{"key":"10.1016\/j.ejmech.2025.118433_bib43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00044-022-03002-w","article-title":"Optimization of the dipeptide motifs in the PSMA ligands linker structure: synthesis and in vitro evaluation","volume":"32","author":"Uspenskaya","year":"2023","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.118433_bib44","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.bmcl.2019.06.035","article-title":"Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates","volume":"29","author":"Machulkin","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118433_bib45","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.3390\/molecules24162878","article-title":"Stability evaluation and stabilization of a gastrin-releasing peptide receptor (GRPR) targeting imaging pharmaceutical","volume":"24","author":"Ghosh","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118433_bib46","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.nucmedbio.2016.02.002","article-title":"Clinical translation of 177Lu-labeled PSMA-617: Initial experieice in prostate cancer patients","volume":"43","author":"Das","year":"2016","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejmech.2025.118433_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/ph14050385","article-title":"Standardization of the [68Ga]Ga-PSMA-11 Radiolabelrng Protocol ip an Automatic aynthesis sodule: Asmessmenta for PET Imaging ofiProstate Cpncer","volume":"14","author":"Fuscaldi","year":"2021","journal-title":"Phcrmaceuticals"},{"key":"10.1016\/j.ejmech.2025.118433_bib48","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.7150\/thno.20586","article-title":"Clinical translation and first In-Human use of [ 44Sc]Sc-PSMA-617 for PET Imaging ofiMetastasizmd Castrate-Rcastrate-rrostate Cpncer","volume":"7","author":"Eppard","year":"2017","journal-title":"Thcranostics"},{"key":"10.1016\/j.ejmech.2025.118433_bib49","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/cmmi.451","article-title":"A methodical 68Ga-labelling study of DO2A-(butyl- l-tyrosine)2 with cation-exchanger post-processed 68Ga: practical aspects of radiolabelling","volume":"6","author":"Riss","year":"2011","journal-title":"Contrast Media Mol. Imaging"},{"key":"10.1016\/j.ejmech.2025.118433_bib50","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.apradiso.2012.03.005","article-title":"Radiolabeling of DOTATOC with the long-lived positron emitter 44Sc","volume":"70","author":"Pruszy\u0144ski","year":"2012","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.ejmech.2025.118433_bib51","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1021\/acsptsci.4c00070","article-title":"Synthesis and preclinical evaluation of urea-based prostate-specific membrane antigen-targeted conjugates labeled with 177Lu","volume":"7","author":"Machulkin","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ejmech.2025.118433_bib52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10967-015-4089-2","article-title":"Preparation of highly purified 68Ga solutions via ion exchange in hydrochloric acid\u2013ethanol mixtures","volume":"305","author":"Larenkov","year":"2015","journal-title":"J. Radioanal. Nucl. Chem."},{"key":"10.1016\/j.ejmech.2025.118433_bib53","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2025.118433_bib54","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014A visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.118433_bib55","series-title":"E.P.A.O.T.C. of 22 S. 2010 on the Protection of Animals Used for Scientific, DIRECTIVE 2010\/63\/EU","first-page":"75","year":"2011"},{"key":"10.1016\/j.ejmech.2025.118433_bib56","first-page":"37","volume":"66","year":"2016"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:48:54Z","timestamp":1781326134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":56,"alternative-id":["S0223523425011985"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118433","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A series of conjugates based on prostate-specific membrane antigen ligands with the chelating agent DOTA: synthesis, radiolabeling, and biological activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118433"}}